ACHC INVESTOR ALERT: Lead Plaintiff Deadline Quickly Approaching; Robbins LLP Urges Shareholders to Seek Counsel

Core Viewpoint - A class action lawsuit has been filed against Acadia Healthcare Company, alleging that the company held patients against their will and engaged in misleading practices regarding its business model and billing [1][2]. Group 1: Allegations and Complaints - The lawsuit claims that Acadia Healthcare's business model involved holding vulnerable patients against their will, even when it was not medically necessary [2]. - It is alleged that many patients experienced abuse while in Acadia's facilities [2]. - The company is accused of deceiving insurance providers into covering costs for patients who did not require hospitalization [2]. Group 2: Stock Price Impact - Following a New York Times article detailing the allegations, Acadia's stock price dropped by $3.72 per share, or 4.5%, closing at $78.21 on September 3, 2024 [3]. - After Acadia disclosed receiving a grand jury subpoena related to its admissions and billing practices, the stock fell by $12.38 per share, or 6.36%, closing at $63.28 on September 27, 2024 [4]. Group 3: Class Action Participation - Investors who purchased Acadia Healthcare securities between February 28, 2020, and September 26, 2024, may be eligible to participate in the class action [1]. - Shareholders interested in serving as lead plaintiffs must submit their applications by December 16, 2024 [5].